Molecular aspects of improving physical performance in conditions of short-term hypobaric hypoxia and pharmacological pseudohypoxia
- Authors: Krytsyna U.V.1, Kharitonova O.V.1, Pozdnyakov D.I.1, Temirbulatova A.M.1, Skulte I.V.1
-
Affiliations:
- Volgograd State Medical University
- Issue: Vol 24, No 4 (2026)
- Pages: 3-7
- Section: Original research
- URL: https://journals.eco-vector.com/1728-2918/article/view/717226
- DOI: https://doi.org/10.29296/24999490-2026-04-01
- EDN: https://elibrary.ru/akqric
- ID: 717226
Cite item
Abstract
Background. Hypoxic training are actively used in both professional and amateur sports. Hypoxia triggers a number of adaptive mechanisms aimed at improving stamina. However, these compensatory and adaptive pathways can be activated through rational pharmacological exposure, inducing pseudohypoxia.
The aim of the study was to compare the molecular mechanisms of performance enhancement in short-term hypobaric hypoxia and pharmacological pseudohypoxia.
Material and methods. Hypobaric hypoxia was simulated in male C57BL/6 mice by placing the animals in a pressure chamber with 14% oxygen content and reduced atmospheric pressure (equivalent to 4000 m above sea level). Pseudohypoxia was reproduced by a course of administration of a succinate dehydrogenase inhibitor – sodium polydihydroxyphenylene thiosulfonate, orally at a dose of 2.1 mg/kg. A combined exposure option was also simulated in animals: hypoxia + pseudohypoxia. After 21 days, the level of physical activity of the animals was recorded in the forced swimming test. Next, the concentrations of Hif-1α, AMP-activated protein kinase, and insulin receptors in muscle tissue, as well as erythropoietin, insulin-like growth factor-1, and cortisol in blood serum were evaluated.
Results. It has been shown that both in conditions of hypobaric hypoxia and pharmacological pseudohypoxia, as well as their combined variants, there is an increase in the concentration of Hif-1α, AMP-activated protein kinase and insulin receptors in muscle tissue. An increase in serum erythropoietin concentration of 51.8% (p < 0.05) was noted in hypobaric hypoxia, which was not observed in the case of pseudohypoxia and combined exposure. It is also worth noting that the physical performance of the animals to which the combined treatment option was applied was significantly higher than in mice that were simulated hypoxia (by 41.8%; p < 0.05) and pseudohypoxia (by 64.1%; p < 0.05). Cortisol concentration are not change in all groups.
Conclusion. In order to increase the level of physical activity through the activation of Hif-1α and insulin-dependent cellular signaling mechanisms, it is advisable to combine hypobaric hypoxic effects and pharmacological pseudohypoxia.
Keywords
About the authors
Ulyana V. Krytsyna
Volgograd State Medical University
Author for correspondence.
Email: ukrytsyna@mail.ru
ORCID iD: 0009-0007-4346-025X
6th year student, Medical Biochemistry specialty. Pyatigorsk Medical and Pharmaceutical Institute
Russian Federation, Kalinin Ave., 11, Pyatigorsk, Stavropol Region, 357532Olga V. Kharitonova
Volgograd State Medical University
Email: incentra@mail.ru
ORCID iD: 0000-0001-7840-9269
Associate Professor of the Department of biological chemistry. Pyatigorsk Medical and Pharmaceutical Institute ; Candidate of Biological Sciences
Russian Federation, Kalinin Ave., 11, Pyatigorsk, Stavropol Region, 357532Dmitry I. Pozdnyakov
Volgograd State Medical University
Email: Pozdniackow.dmitry@yandex.ru
ORCID iD: 0000-0002-5595-8182
Associate Professor, Head of the Department of Pharmacology with a course in clinical pharmacology. Pyatigorsk Medical and Pharmaceutical Institute; Candidate of Pharmaceutical Sciences
Russian Federation, Kalinin Ave., 11, Pyatigorsk, Stavropol Region, 357532Anna M. Temirbulatova
Volgograd State Medical University
Email: anna_vladimir@inbox.ru
ORCID iD: 0000-0002-9588-1706
Associate Professor of the Department of biological chemistry. Pyatigorsk Medical and Pharmaceutical Institute; Candidate of Pharmaceutical Sciences
Russian Federation, Kalinin Ave., 11, Pyatigorsk, Stavropol Region, 357532Irina V. Skulte
Volgograd State Medical University
Email: skulteiv@mail.ru
ORCID iD: 0009-0008-8410-9797
Associate Professor of the Department of biological chemistry. Pyatigorsk Medical and Pharmaceutical Institute; Candidate of Pharmaceutical Sciences
Russian Federation, Kalinin Ave., 11, Pyatigorsk, Stavropol Region, 357532References
- Allsopp G.L., Britto F.A., Wright C.R., Deldicque L. The Effects of Normobaric Hypoxia on the Acute Physiological Responses to Resistance Training: A Narrative Review. J. Strength Cond Res. 2024; 38 (11): 2001–11. doi: 10.1519/JSC.0000000000004909.
- Mujika I., Sharma A.P., Stellingwerff T. Contemporary Periodization of Altitude Training for Elite Endurance Athletes: A Narrative Review. Sports Med. 2019; 49 (11): 1651–69. doi: 10.1007/s40279-019-01165-y.
- Camacho-Cardenosa A., Camacho-Cardenosa M., Burtscher J., Olivares P.R., Olcina G., Brazo-Sayavera J. Intermittent Hypoxic Training Increases and Prolongs Exercise Benefits in Adult Untrained Women. High Alt Med Biol. 2024; 25 (4): 274–84. doi: 10.1089/ham.2023.0127.
- Guo H., Cheng L., Duolikun D., Yao Q. Aerobic Exercise Training Under Normobaric Hypoxic Conditions to Improve Glucose and Lipid Metabolism in Overweight and Obese Individuals: A Systematic Review and Meta-Analysis. High Alt Med. Biol. 2023; 24 (4): 312–20. doi: 10.1089/ham.2022.0099
- Catrina S.B. Impaired hypoxia-inducible factor (HIF) regulation by hyperglycemia. J. Mol. Med. (Berl). 2014; 92 (10): 1025–34. doi: 10.1007/s00109-014-1166-x.
- Косенко Е.А., Абрамова М.Б., Венедиктова Н.И., Попова И.И., Каминский Ю.Г. Медикамент гипоксен новый ингибитор митохондриального дыхания и митохондриальных дегидрогеназ. Известия Российской академии наук. Серия биологическая. 2010; 4: 411–6. [Kosenko E.A., Abramova M.B., Venediktova N.I., Popova I.I., Kaminsky Yu.G. The drug hypoxene is a new inhibitor of mitochondrial respiration and mitochondrial dehydrogenases. Proceedings of the Russian Academy of Sciences. The biological series. 2010; 4: 411–6 (In Russian)].
- Food and Drug Administration (FDA). Guidance for Industry. Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers 2005. Режим доступа: https://www.fda.gov/media/72309/download. (посещение 28.05.2025).
- Воронков А.В., Поздняков Д.И., Воронкова М.П. Комплексная валидационная оценка нового методического подхода к изучению физического и психоэмоционального перенапряжения в эксперименте. Фундаментальные исследования. 2015; 1–5: 915–9. [Voronkov A.V., Pozdnyakov D.I., Voronkova M.P. Comprehensive validation assessment of a new methodological approach to the study of physical and psycho-emotional overstrain in experiment. Fundamental research. 2015; 1–5: 915–9 (In Russian)].
- Lang T.A., Altman D.G. Basic statistical reporting for articles published in biomedical journals: the «Statistical Analyses and Methods in the Published Literature» or the SAMPL Guidelines. Int. J. Nurs Stud. 2015; 52 (1): 5–9. doi: 10.1016/j.ijnurstu.2014.09.006.
- Lee P., Chandel N.S., Simon M.C. Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat Rev Mol. Cell Biol. 2020; 21 (5): 268–83. doi: 10.1038/s41580-020-0227-y.
- Thomas L.W., Ashcroft M. Exploring the molecular interface between hypoxia-inducible factor signalling and mitochondria. Cell Mol. Life Sci. 2019; 76 (9): 1759–77. doi: 10.1007/s00018-019-03039-y.
- Park H.Y., Lim K. Effects of Hypoxic Training versus Normoxic Training on Exercise Performance in Competitive Swimmers. J. Sports Sci Med. 2017; 16 (4): 480–8.
- Herzig S., Shaw R.J. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol. Cell Biol. 2018; 19 (2): 121–35. doi: 10.1038/nrm.2017.95.
- Shi S., Ou X., Liu C., Wen H., Ke J. Research progress of HIF-1a on immunotherapy outcomes in immune vascular microenvironment. Front Immunol. 2025; 16: 1549276. doi: 10.3389/fimmu.2025.1549276.
- Lau S.S., Kuhlman C.L., Bratton S.B., Monks T.J. Role of hydroquinone-thiol conjugates in benzene-mediated toxicity. Chem Biol Interact. 2010; 184 (1–2): 212–7. doi: 10.1016/j.cbi.2009.12.016.
Supplementary files
